$13.38▾ 2.19%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
+31.6%year over year
Strong
Revenue is growing strongly year over year.
Leverage
Lowdebt to assets
Healthy
A modest, well-covered debt load.
More coming: dilution / share-count creep.
Fair value
Overvalued
Trading about 210% above our fair-value range
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
Alignment Healthcare, Inc.'s earnings-quality signal is not available yet. Revenue is growing strongly year over year. A modest, well-covered debt load.
Key numbers
Valuation
EPS (TTM)$0.19
TTM (trailing 12 months, through fiscal Q2 FY2026)
Profitability
Net margin0.9%
TTM (trailing 12 months, through fiscal Q2 FY2026)
Size
Revenue (TTM)$4.58B
TTM (trailing 12 months, through fiscal Q2 FY2026)
Recent news
Sentiment · last 30 days10 articles
0 bullish0 neutral10 bearish
Lowey Dannenberg, P.C. is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Violations of the Federal Securities Laws
Alignment Healthcare, Inc. Investigated by the Portnoy Law Firm
Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Learn More About the Investigation of Potential Securities Law Violations
ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation
Signals and key numbers are from the fiscal Q2 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.